Kathleen Meyer – Biography
Last update: April 16, 2026Executive profile
Kathleen was Principal Scientist at Biomarin Pharmaceutical, and Senior Director, Preclinical Safety Evaluation at Xoma Royalty. Kathleen served as Senior Director, Toxicology at Sangamo Therapeutics.
Kathleen Meyer is currentlyVice President, Nonclinical Development at Sangamo Therapeutics - View - Sangamo Therapeutics org chart
Create your alert
to follow the career of Kathleen Meyer.
Education
Kathleen Meyer has a Master in Public Health from University of California, Berkeley and a Doctor of Philosophy, Environmental Health Sciences, Toxicology, Epidemiology from University of California, Berkeley.
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
They have also studied at University of California, Berkeley :
Find more alumni from University of California, Berkeley
More about Kathleen Meyer
Do you need to know more about Kathleen Meyer? More results.
Participate
Social media
- Kathleen Meyer on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Kathleen Meyer
The colleagues of Kathleen Meyer
Company Colleagues
- At Sangamo Therapeutics, Kathleen Meyer has 21 colleagues including Sandy Macrae (CEO & Director), Robert Carey (Director)…
Homonyms
- Kathleen Meyer - Manager of Human Resources - Daimler Buses Belgium
Industry Colleagues
- In the Pharmaceuticals industry, Kathleen Meyer has 22,989 colleagues in 1,914 companies located in 68 countries. 10,852 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Kathleen Meyer.
Get in Touch
Here are a few tips for establishing great contacts.
